Bottom line
Is MTRA a good fund? The bottom line
MTRA is an actively managed international stock ETF from Invesco.
Its expense ratio is 0.54% — about $54 a year on every $10,000 invested, cheaper than 82% of international stock funds we track.
With $140 million in net assets and 54 holdings, its largest position is Taiwan Semiconductor Manufacturing Co. Ltd. (9.4%) and the top 10 make up 37.6% of the portfolio.
What stands out
- Low cost: cheaper than 82% of international stock peers
Updated Nov 19, 2026
What MTRA invests in
The Invesco International Growth Focus ETF (the Fund) seeks to provide capital appreciation.
The Fund seeks to achieve its investment objective by investing, under normal market conditions, primarily in the equity securities (as well as American depositary receipts (ADRs) and global depositary receipts (GDRs) that represent such securities) of growth companies that are domiciled or have their primary operations outside of the United States. Under normal circumstances, the Fund will invest at least 80% of the value of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of issuers that are considered by the Funds portfolio managers to have potential for earnings or revenue growth and in derivatives and other instruments that have economic characteristics similar to such securities. Under normal market conditions, the Fund will invest at least 65% of its total assets in common and/or preferred stocks of issuers in at least three…
From the fund's prospectus (filed Feb 26, 2026).
What MTRA costs
On a $10,000 investment, MTRA's 0.54% expense ratio costs about $54 a year. The median international stock fund charges 0.9%.
MTRA top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Co. Ltd. | 9.38% |
| 2 | ASML Holding N.V. | 6.06% |
| 3 | Siemens AG | 4.20% |
| 4 | Contemporary Amperex Technology Co., Ltd. | 2.90% |
| 5 | Lonza Group AG | 2.78% |
| 6 | Mitsubishi Ufj Financial Group, Inc. | 2.63% |
| 7 | Airbus SE | 2.51% |
| 8 | Novo Nordisk A/S | 2.41% |
| 9 | Reliance Industries Ltd. | 2.37% |
| 10 | Invesco Private Prime Fund | 2.35% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 37.6% of the fund. See all top 25 holdings and asset mix →